Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02376842 · ClinicalTrials.gov registry record · NA
Study of an Electronic Health Record-embedded Severe Sepsis Early Warning Alert
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 1,149
- Enrollment target
NCT02376842: Completed NA study, sponsored by Stanford University.
NCT02376842 is a NA study that has completed, run by Stanford University. The registered enrollment target is 1,149 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (18% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02376842, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,149 participants
- Enrollment target
Study Summary
The investigators hypothesize that implementing an electronic health record-based early warning system for severe infections (severe sepsis) will decrease the time to antibiotic order. The study will consist of an algorithm which will monitor lab values, vital signs, and nursing documentation for signs of severe sepsis. When these criteria are met, an alert will be delivered via the electronic health record to a nurse and doctor and simultaneously an alert via pager to another nurse. The investigators plan to randomize which patients will generate these alerts and analyze the data after collecting information for approximately 6 months which will be sufficient to detect a 10% difference in the two patient groups.
Primary Outcome
Time from when the alert fires until appropriate antibiotics are ordered will be measured via the electronic health record and a sample of cases will be verified by manual chart review.
Interventions
- BEHAVIORAL Standard care
- BEHAVIORAL Severe sepsis early warning best practice alert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,149 participants |
| Start Date | 2014-11 |
| Est. Completion | 2015-03 |
| Phase | NA |
What the finished NCT02376842 record still lists
NCT02376842 is an interventional study that assigns participants to a tested intervention. Its 1,149 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (18% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard care is the first listed.
NCT02376842 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02376842 about?
NCT02376842 is a clinical study titled "Study of an Electronic Health Record-embedded Severe Sepsis Early Warning Alert". The investigators hypothesize that implementing an electronic health record-based early warning system for severe infections (severe sepsis) will decrease the time to antibiotic order. The study will consist of an algorithm which will monitor lab values, vital signs, and nursing documentation for si...
What is the current status of trial NCT02376842?
This trial is currently completed. It is a NA study. The enrollment target is 1,149 participants. The study started on 2014-11. Estimated completion is 2015-03.
What interventions are being tested in trial NCT02376842?
The interventions under investigation include: Standard care (BEHAVIORAL), Severe sepsis early warning best practice alert (BEHAVIORAL).
Who is sponsoring clinical trial NCT02376842?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02376842's enrollment target sits among peer trials
1,149 92nd of 2000 higher than 1,909 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06408181 · 1,150 participants · Phase 3
APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia
- NCT06528314 · 1,150 participants · Phase 3
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- NCT07293559 · 1,150 participants
Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States
- NCT07339423 · 1,150 participants · Phase 3
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia